statistiche ricercatore

Continente	#
NA - Nord America	503
AS - Asia	313
EU - Europa	269
SA - Sud America	42
AF - Africa	20
OC - Oceania	2
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.150

Nazione	#
US - Stati Uniti d'America	491
CN - Cina	131
IE - Irlanda	83
SG - Singapore	80
RU - Federazione Russa	45
HK - Hong Kong	37
DE - Germania	32
IT - Italia	31
BR - Brasile	29
VN - Vietnam	23
FR - Francia	19
ZA - Sudafrica	17
FI - Finlandia	14
GB - Regno Unito	12
CA - Canada	8
IN - India	8
PL - Polonia	7
TR - Turchia	7
AR - Argentina	5
BD - Bangladesh	5
JP - Giappone	5
LT - Lituania	4
SE - Svezia	4
AT - Austria	3
BE - Belgio	3
MX - Messico	3
PK - Pakistan	3
AU - Australia	2
EC - Ecuador	2
ES - Italia	2
NL - Olanda	2
PH - Filippine	2
UA - Ucraina	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
AM - Armenia	1
BA - Bosnia-Erzegovina	1
BY - Bielorussia	1
CH - Svizzera	1
CL - Cile	1
CO - Colombia	1
CW - ???statistics.table.value.countryCode.CW???	1
CZ - Repubblica Ceca	1
GE - Georgia	1
ID - Indonesia	1
IL - Israele	1
IQ - Iraq	1
IR - Iran	1
JM - Giamaica	1
KZ - Kazakistan	1
ML - Mali	1
MN - Mongolia	1
MU - Mauritius	1
NP - Nepal	1
PE - Perù	1
PT - Portogallo	1
SA - Arabia Saudita	1
SC - Seychelles	1
SR - Suriname	1
UZ - Uzbekistan	1
Totale	1.150

Nome	#
Inter-observer agreement on the morphology of screening-detected lung cancer: beyond pulmonary nodules and masses	163
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1	128
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome	126
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome	121
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3	116
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome	109
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)	91
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients	90
Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome	90
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy	66
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment-Authors' reply	66
Totale	1.166

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	3	0	0	0	0	0	0	0	0	0	3	0	0
2021/2022	34	0	0	2	0	0	0	0	2	2	4	4	20
2022/2023	199	16	14	11	12	11	22	0	9	99	0	4	1
2023/2024	83	17	12	3	4	4	16	9	5	2	0	3	8
2024/2025	220	10	13	2	3	11	23	10	16	64	11	23	34
2025/2026	451	37	23	45	61	73	23	80	24	45	40	0	0
Totale													1.166